3543-72-4: Bendamustine Nitro Ethyl Ester Impurity
It is a Bendamustine intermediate. Bendamustine is employed to treat bound sorts of cancer (such as cancer, and chronic leukemia – CLL). Bendamustine belongs to a category of cancer therapy medicine called alkylating agents. It works by killing cancer cells or fastness their growth.
Additional information on CAS 3543-72-4
Catalogue No.
VE007302
CAS No.
3543-72-4
Molecular Formula
C14H17N3O4
Molecular Weight
291.3 g/mol
Parent drug
Bendamustine
IUPAC Name
ethyl 4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl)butanoate
Synonyms
N/A
References
“Sci-Hub, Bendamustine, 10.2165/00003495-200161050-00009.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.2165/00003495-200161050-00009.
Status
In-stock
Other products related to bendamustine
CAS No. | Name of Impurity | Parent Drug | Catalogue No. |
---|